A study of fruit flies shows that the benefits of protective bacteria, which safeguard organisms from further disease without causing harm, depend on how subsequent infections enter the body.
Scientists made their discovery studying the bacteria Wolbachia, which in itself does not cause disease but benefits its thousands of host species in many ways, including protecting from other infections.
They found that insects, which carried Wolbachia and then contracted another infection through feeding - as they would in the wild - fought disease better than those which had the same infection injected into their bodies.
Researchers say that studies which focus on natural routes of infection could improve our understanding of immunity in many species.
Their study also resolves a long-term puzzle for scientists. It confirms that Wolbachia, which is known to provide protection from bacterial infections in other insect species, offers the same benefit in flies.
The team observed this finding in flies that had been infected orally, but not in those infected via an injection.
Researchers from the University of Edinburgh studied bacterial infection in fruit flies, some of which were carrying Wolbachia bacteria.
When infected with another bacterial infection, either orally or by injection, flies carrying Wolbachia which had been infected orally were best able to fight the disease. Further analysis showed these flies' immune systems had triggered production of antimicrobial and detoxifying molecules in response to the infection.
Researchers also found that male flies experienced greater disease protection with Wolbachia than females, and suggest a greater focus on differences in immune response to infection between the sexes.
Dr Pedro Vale, of the University of Edinburgh's School of Biological Sciences, who led the study, said, "Most experimental studies employ artificial routes of infection, and we may be missing out on important aspects of biology. Understanding more about the impact of contracting infection through natural routes could add to our body of knowledge about immune responses and disease."
The study is published in Proceedings of the Royal Society B.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
